TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
A trial is currently underway in Illinois as a widow seeks to hold pharmaceutical manufacturer GlaxoSmithKline accountable for improper labeling and minimizing a potentially serious side effect of a well-known antidepressant. Paroxetine is a widely prescribed antidepressant and anti-anxiety drug under the class of drugs known as selective serotonin reuptake inhibitors (SSRIs). Paroxetine is most commonly known Read More…
Critics are calling attention to the relationship between pharmaceutical companies and President Trump’s nominee to the Food and Drug Administration. Dr. Scott Gottlieb is promising to recuse himself from more than 20 companies he is involved with should he be accepted as the head of the Food and Drug Administration. Gottlieb made the promise after Read More…
The Republican-controlled Committee on Oversight and Government Reform approved a bill earlier today to allow for a congressional audit of the Federal Reserve’s monetary policy, a proposal Fed policymakers have opposed and likely faces a difficult path to final approval in the Senate. Under the bill, the Fed’s monetary policy deliberations could be subject to Read More…
Riddle me this: As we all know by now, China is bleeding capital, with a record $725 billion in outflows last year alone. Accordingly, the ChiComs have been flipping their lid, imposing new capital controls left and right to try and stop the bleeding. One of the most straightforward of these capital controls limits each Read More…
As Attorney General Jeff Sessions continues to lament what he views as a blight on society, a new study is showing that states with medical marijuana programs are seeing drastic reductions in opioid-related hospitalizations and overdoses. From a Reuters article published Tuesday: “In states that legalized medical marijuana, U.S. hospitals failed to see a predicted influx Read More…
Today, the West Virginia House unanimously passed a bill that would significantly expand the state’s hemp licensing program, opening the door for anybody in the state to produce or process industrial hemp for commercial purposes. Final approval would set the foundation to end federal prohibition in practice. Del. Jeff Eldridge (D-Alum Creek) and Del. Jim Butler (R-Henderson) Read More…